Mosaic ImmunoEngineering Inc. SEC filings CPMV
Mosaic ImmunoEngineering Inc. has 553 filings in SEC EDGAR's recent list, going back to Dec 11, 1995. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 2, 2025 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Jun 25, 2021 | Jun 25, 2021 |
| PRE 14C | Preliminary information statement | Jun 15, 2021 | Jun 30, 2021 |
| DEF 14C | Information statement | Nov 2, 2020 | Oct 27, 2020 |
| PRE 14C | Preliminary information statement | Oct 23, 2020 | Oct 27, 2020 |
| DEFA14A | Additional proxy material | Apr 18, 2018 | — |
| DEF 14A | Proxy statement | Apr 18, 2018 | Apr 18, 2018 |
| DEF 14A | Proxy statement | Mar 15, 2017 | May 4, 2017 |
| DEF 14A | Proxy statement | Mar 18, 2016 | Apr 28, 2016 |
| PRE 14A | Preliminary proxy statement | Mar 8, 2016 | Apr 28, 2016 |
| DEF 14A | Proxy statement | Mar 9, 2015 | Apr 30, 2015 |
| DEF 14A | Proxy statement | Mar 11, 2014 | Apr 30, 2014 |
| DEF 14A | Proxy statement | Mar 11, 2013 | Apr 30, 2013 |
| DEF 14A | Proxy statement | Dec 21, 2011 | Feb 10, 2012 |
| DEF 14A | Proxy statement | Nov 30, 2010 | Nov 30, 2010 |
| DEF 14A | Proxy statement | Dec 8, 2009 | Jan 28, 2010 |
| DEFA14A | Additional proxy material | Oct 23, 2008 | — |
| DEF 14A | Proxy statement | Sep 22, 2008 | Oct 30, 2008 |
| PRE 14A | Preliminary proxy statement | Sep 12, 2008 | Oct 30, 2008 |
| DEF 14A | Proxy statement | Sep 27, 2007 | Sep 25, 2007 |
| DEF 14A | Proxy statement | Apr 2, 2007 | Apr 27, 2007 |
| DEF 14A | Proxy statement | Apr 5, 2006 | Apr 28, 2006 |
| DEF 14A | Proxy statement | Mar 14, 2005 | Apr 14, 2005 |
| PRE 14A | Preliminary proxy statement | Mar 1, 2005 | Mar 1, 2005 |
| DEF 14A | Proxy statement | Sep 17, 2003 | Oct 16, 2003 |
| PRE 14A | Preliminary proxy statement | Sep 4, 2003 | Oct 16, 2003 |
| DEF 14A | Proxy statement | Mar 25, 2002 | May 6, 2002 |
| PRE 14A | Preliminary proxy statement | Mar 13, 2002 | May 6, 2002 |
| DEF 14A | Proxy statement | Sep 12, 2001 | Oct 11, 2001 |
| PRE 14A | Preliminary proxy statement | Aug 31, 2001 | Oct 11, 2001 |
| DEF 14A | Proxy statement | Mar 13, 2000 | Apr 28, 2000 |
| PRE 14A | Preliminary proxy statement | Dec 29, 1999 | Feb 4, 2000 |
| DEF 14A | Proxy statement | Oct 15, 1997 | Dec 4, 1997 |
| DEF 14A | Proxy statement | Apr 22, 1996 | May 17, 1996 |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CPMV (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Huntington Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 836564
- Former names
- PATRIOT SCIENTIFIC CORP (until Nov 19, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.